Literature DB >> 30916776

Vitamin D as an immune modulator in multiple sclerosis.

Halina Bartosik-Psujek1, Marek Psujek2.   

Abstract

Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative disorder of the central nervous system. The disease is characterised by inflammation with extensive immune infiltration, demyelination, axonal loss and damage of oligodendrocytes, presumably auto-immune in nature. The influence of environmental factors on the development and activity of MS has been known for a long time. Vitamin D and sun exposure are among the most important ones. Both serum vitamin D level and sun exposure independent of vitamin D production are correlated with epidemiological and clinical parameters of MS, and the impact of vitamin D on immune parameters has been clearly confirmed in experimental studies. Nevertheless, the impact on clinical aspects is inconclusive, especially when the influence of supplementation is assessed. In this work we review the state of knowledge regarding the effect of vitamin D on immune cells subsets in relation to experimental and clinical studies.

Entities:  

Keywords:  B cells; T cells; dendritic cells; macrophages; multiple sclerosis; supplementation; vitamin D

Mesh:

Substances:

Year:  2019        PMID: 30916776     DOI: 10.5603/PJNNS.a2019.0015

Source DB:  PubMed          Journal:  Neurol Neurochir Pol        ISSN: 0028-3843            Impact factor:   1.621


  6 in total

Review 1.  Pathology-supported genetic testing as a method for disability prevention in multiple sclerosis (MS). Part II. Insights from two MS cases.

Authors:  Susan J van Rensburg; Coenraad Hattingh; Clint Johannes; Kelebogile E Moremi; Armand V Peeters; Carel J van Heerden; Rajiv T Erasmus; Annalise E Zemlin; Merlisa C Kemp; Mariaan Jaftha; Aye Aye Khine; Felix C V Potocnik; Lindiwe Whati; Penelope Engel-Hills; Ronald van Toorn; Maritha J Kotze
Journal:  Metab Brain Dis       Date:  2021-03-12       Impact factor: 3.584

Review 2.  Pathology-supported genetic testing as a method for disability prevention in multiple sclerosis (MS). Part I. Targeting a metabolic model rather than autoimmunity.

Authors:  Susan J van Rensburg; Ronald van Toorn; Rajiv T Erasmus; Coenraad Hattingh; Clint Johannes; Kelebogile E Moremi; Merlisa C Kemp; Penelope Engel-Hills; Maritha J Kotze
Journal:  Metab Brain Dis       Date:  2021-04-28       Impact factor: 3.584

3.  Comprehensive Stability Study of Vitamin D3 in Aqueous Solutions and Liquid Commercial Products.

Authors:  Žane Temova Rakuša; Mitja Pišlar; Albin Kristl; Robert Roškar
Journal:  Pharmaceutics       Date:  2021-04-25       Impact factor: 6.321

Review 4.  Immunomodulatory Effects of Vitamin D in Thyroid Diseases.

Authors:  Chiara Mele; Marina Caputo; Alessandro Bisceglia; Maria Teresa Samà; Marco Zavattaro; Gianluca Aimaretti; Loredana Pagano; Flavia Prodam; Paolo Marzullo
Journal:  Nutrients       Date:  2020-05-16       Impact factor: 5.717

5.  Skin Phototype Could Be a Risk Factor for Multiple Sclerosis.

Authors:  Patricia Urbaneja; Isaac Hurtado-Guerrero; Miguel Ángel Hernández; Begoña Oliver-Martos; Celia Oreja-Guevara; Jesús Ortega-Pinazo; Ana Alonso; Francisco J Barón-López; Laura Leyva; Óscar Fernández; María Jesús Pinto-Medel
Journal:  J Clin Med       Date:  2020-07-26       Impact factor: 4.241

6.  Adequacy and Vitamin D in the Preoperative Period of Roux-en-Y Gastric Bypass, Bariatric Surgery, Can Protect Metabolic Health in Metabolically Healthy and Unhealthy Individuals.

Authors:  Suelem Pereira da Cruz; Sabrina Cruz; Silvia Pereira; Carlos Saboya; Juliana Castelar Lack Veiga; Andréa Ramalho
Journal:  Nutrients       Date:  2022-01-18       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.